Entities / Entity
valoctocogene roxaparvovec.
experimental gene therapy for hemophilia A
- Reports this week
- 0
- Active events
- 0
- Connections
- 2
What's happening
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around valoctocogene roxaparvovec this week
News at the entities that move valoctocogene roxaparvovec most-
BioMarin Pharmaceutical StructuralInvestors are comparing the financial performance metrics of BioMarin Pharmaceutical and Metagenomi.Moves valoctocogene roxaparvovec
Connections
The 1 strongest of 2, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
BioMarin Pharmaceutical Structural
BioMarin Pharmaceutical is the developer and presenter of data regarding the product valoctocogene roxaparvovec.